Dachaigh › Ailseachadh an Ae (Carcinoma Hepatocellular) › California › Los Angeles
Sgrùdaidhean clionaigeach Ailseachadh an Ae (Carcinoma Hepatocellular) ann an Los Angeles, CA
Tha 19 sgrùdaidhean airson Ailseachadh an Ae (Carcinoma Hepatocellular) a’ lorg phàirtichean aig làraichean ann agus timcheall air Los Angeles (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
A’ fastadhÌre 1/2
- START Los Angeles, LLC, Los Angeles
- Keck Hospital of USC, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- agus 3 a bharrachd
National Liver Cancer Screening Trial
A’ fastadhÌre 4
- University of Southern California, Los Angeles
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
A’ fastadhÌre 1/2
- Local Institution - 0070, Los Angeles
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
A’ fastadhÌre 1
- USC Norris Comprehensive Cancer Center, Los Angeles
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
A’ fastadhÌre 2
- USC Norris Comprehensive Cancer Center, Los Angeles
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
A’ fastadhSgrùdadh amharc
- Cedars-Sinai Medical Center, Los Angeles
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
A’ fastadhÌre 3
- Research Site, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
A’ fastadhÌre 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
A’ fastadhÌre 1/2
- Children's Hospital Los Angeles, Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- University of California, Los Angeles (UCLA), Los Angeles
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
A’ fastadhÌre 1/2
- Research Site, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- The Angeles Clinic and Research Institute, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
A’ fastadhÌre 1/2
- Los Angeles Cancer Network, Los Angeles
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
A’ fastadhÌre 1/2
- Children's Hospital Los Angeles, Los Angeles
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
A’ fastadhÌre 1
- Clinical Trial Site, Los Angeles
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
A’ fastadhÌre 2
- USA06-0, Los Angeles
- USA16-0, Los Angeles
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
A’ fastadhÌre 1/2
- Norris Comprehensive Cancer Center, Los Angeles
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
A’ fastadhSgrùdadh amharc
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
Sgrùdaidhean Ailseachadh an Ae (Carcinoma Hepatocellular) ann am bailtean eile
- Houston, TX31 sgrùdaidhean
- New York City, NY24 sgrùdaidhean
- Dallas, TX19 sgrùdaidhean
- Boston, MA18 sgrùdaidhean
- Cleveland, OH18 sgrùdaidhean
- Chicago, IL16 sgrùdaidhean
- Philadelphia, PA16 sgrùdaidhean
- Pittsburgh, PA15 sgrùdaidhean
- San Francisco, CA14 sgrùdaidhean
- Orange, CA14 sgrùdaidhean
- Jacksonville, FL14 sgrùdaidhean
- San Antonio, TX13 sgrùdaidhean
Sgrùdaidhean eile ann an Los Angeles
- Aillse Sgamhain Neo-chealla-beag87 sgrùdaidhean
- Aillse (gach seòrsa)74 sgrùdaidhean
- Aillse a' bhroilleach73 sgrùdaidhean
- Aillse Prostata61 sgrùdaidhean
- Aillse colorectal59 sgrùdaidhean
- Ailse metastatach57 sgrùdaidhean
- Cancer Ovarian50 sgrùdaidhean
- Ailseachadh nan Sgamhan45 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil42 sgrùdaidhean
- Cancer Pancreatic35 sgrùdaidhean
- Ailse Endometrial34 sgrùdaidhean
- Melanoma34 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.